V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10006358 | 10004173 | 1.76 | 103.3 | Palliative (P) | null | 2015-01-12 | GEMCITABINE | null | Y | 10410299 | FLUOROURACIL |
| 10006359 | 10004175 | 1.65 | 71 | Palliative (P) | 2017-07-15 | 2017-07-29 | Carboplatin + Paclitaxel (3 weekly) | N | N | 10410582 | CARBOPLATIN + PACLITAXEL |
| 10006360 | 10004180 | null | null | Palliative (P) | 2015-04-16 | 2015-04-25 | null | Y | N | 10410849 | GEMCITABINE |
| 10006361 | 10004181 | 1.75 | 90.6 | Not known (9) | 2017-06-16 | 2017-07-02 | Azacitidine | 02 | N | 10411050 | AZACITIDINE |
| 10006362 | 10007193 | 1.67 | 65 | Palliative (P) | 2017-05-29 | 2017-06-23 | Bevacizumab | N | N | 10411394 | NOT MATCHED |
| 10006363 | 10008937 | 1.59 | 66.5 | Palliative (P) | 2017-10-09 | 2017-10-30 | GEMCARBO | N | N | 10411550 | BEVACIZUMAB |
| 10006364 | 10008937 | 1.82 | 90 | Disease modification (D) | 2017-04-01 | 2017-04-09 | Trial Unspecified | N | N | 10411550 | TRIAL |
| 10006365 | 10004182 | 1.73 | 69.6 | Curative (C) | 2017-10-21 | 2017-11-17 | CARBOPLATIN + ETOPOSIDE | N | N | 10411624 | CARBOPLATIN + ETOPOSIDE |
| 10006366 | 10004183 | 1.66 | 49 | Palliative (P) | 2017-07-22 | 2017-07-22 | Carboplatin + Vinorelbine Oral | 02 | N | 10411715 | GEMCARBO |
| 10006367 | 10004186 | 1.76 | 0 | Curative (C) | 2016-10-02 | 2016-10-09 | CARBOPLATIN + PACLITAXEL | N | N | 10411839 | CARBOPLATIN + PACLITAXEL |
| 10006368 | 10004189 | 1.72 | 79.4 | null | 2017-09-06 | 2017-09-07 | LENALIDOMIDE | 02 | N | 10412008 | PEMETREXED |
| 10006369 | 10004194 | 1.6 | 58 | c | 2018-07-03 | 2018-07-25 | Carboplatin + Pemetrexed | null | Y | 10412077 | CARBOPLATIN + VINORELBINE |
| 10006370 | 10004195 | 1.75 | 55.1 | Adjuvant (A) | 2017-04-28 | 2017-05-15 | Capecitabine | N | N | 10412185 | CAPECITABINE |
| 10006371 | 10004197 | 1.76 | 72.4 | Adjuvant (A) | 2018-06-08 | 2018-11-24 | Capecitabine | N | N | 10412220 | CAPECITABINE |
| 10006372 | 10004197 | 1.67 | 57 | Adjuvant (A) | 2019-08-16 | 2019-08-17 | CTD | N | N | 10412220 | BCG |
| 10006373 | 10008938 | 1.52 | 63 | Palliative (P) | 2017-12-04 | 2017-12-05 | IBRUTINIB | 02 | N | 10412245 | PEMETREXED |
| 10006374 | 10008938 | 1.81 | null | Palliative (P) | 2016-03-30 | 2016-09-18 | BENDAMUSTINE + RITUXIMAB | N | N | 10412245 | BENDAMUSTINE + RITUXIMAB |
| 10006375 | 10004199 | 1.47 | 71.8 | Palliative (P) | 2017-06-16 | 2017-06-29 | Carboplatin AUC 6 - 10 | N | N | 10412381 | GEMCARBO |
| 10006376 | 10004200 | 1.61 | 66 | null | 2017-08-22 | 2017-08-23 | Carboplatin + Etoposide IV 3 day | N | null | 10412577 | CARBOPLATIN + ETOPOSIDE |
| 10006377 | 10004200 | 1.82 | 115.8 | Palliative (P) | 2017-08-17 | 2017-08-25 | CARBOPLATIN + PACLITAXEL | 02 | N | 10412577 | CARBOPLATIN + PACLITAXEL |
| 10006378 | 10008437 | 1.8 | null | Palliative (P) | 2017-08-07 | 2017-08-29 | CARBOPLATIN + GEMCITABINE | N | N | 10412779 | IBRUTINIB |
| 10006379 | 10008437 | 1.68 | 49 | null | 2013-08-15 | 2013-08-15 | Trial Unspecified | 02 | N | 10412779 | TRIAL |
| 10006380 | 10004201 | 1.7 | null | Disease modification (D) | 2018-01-22 | 2018-01-27 | Fluorouracil + Folinic Acid Weekly | N | N | 10413131 | CTD |
| 10006381 | 10004203 | 1.65 | 84 | Curative (C) | 2018-05-10 | 2018-05-10 | LENALIDOMIDE | N | N | 10413133 | GEMCARBO |
| 10006382 | 10004204 | null | 71 | Palliative (P) | 2017-06-28 | 2017-07-20 | GEMCARBO | 2 | N | 10413612 | FLUOROURACIL |
| 10006383 | 10004204 | 1.68 | 60 | Palliative (P) | 2016-11-29 | 2016-12-20 | LENALIDOMIDE | N | N | 10413612 | LENALIDOMIDE |
| 10006384 | 10004205 | 1.63 | 80.7 | Palliative (P) | 2013-04-28 | 2014-04-03 | Abiraterone | N | N | 10413724 | GEMCARBO |
| 10006385 | 10004205 | null | null | Palliative (P) | 2014-07-27 | 2014-09-28 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | Y | 10413724 | BCG |
| 10006386 | 10004206 | 1.63 | 63 | Palliative (P) | 2018-06-06 | 2018-06-06 | IBRUTINIB | 02 | N | 10414243 | LENALIDOMIDE |
| 10006387 | 10004207 | 1.87 | 77.7 | Palliative (P) | 2014-11-25 | 2014-11-26 | LENALIDOMIDE | 02 | N | 10414363 | LENALIDOMIDE |
| 10006388 | 10004208 | 1.76 | 75.2 | Palliative (P) | 2019-07-29 | 2019-07-30 | Pemetrexed | 02 | null | 10414364 | GEMCITABINE |
| 10006389 | 10004209 | 1.72 | 75.8 | Palliative (P) | 2017-01-12 | 2017-02-14 | Carboplatin + Etoposide IV 3 day | 2 | N | 10414448 | CARBOPLATIN + ETOPOSIDE |
| 10006390 | 10004211 | 1.63 | 69.5 | Curative (C) | null | 2017-07-09 | CARBOPLATIN + ETOPOSIDE | N | N | 10414947 | CARBOPLATIN + ETOPOSIDE |
| 10006391 | 10004212 | 1.68 | 85 | Disease modification (D) | 2019-04-25 | 2019-04-27 | null | N | N | 10414991 | CARBOPLATIN + PEMETREXED |
| 10006392 | 10004213 | 1.65 | null | Adjuvant (A) | 2015-01-07 | 2015-03-18 | LENALIDOMIDE | N | N | 10415459 | GEMCARBO |
| 10006393 | 10004215 | 1.71 | 89.7 | Palliative (P) | 2016-11-26 | 2016-12-06 | Abiraterone | N | N | 10415459 | CVP R |
| 10006394 | 10004216 | 1.68 | 98.3 | Palliative (P) | 2018-02-15 | 2018-03-15 | null | 02 | N | 10416138 | LENALIDOMIDE |
| 10006395 | 10004217 | 1.83 | 78 | Disease modification (D) | 2017-05-24 | 2017-10-12 | Trial Unspecified | N | N | 10416185 | TRIAL |
| 10006396 | 10004218 | null | 49 | Adjuvant (A) | 2017-09-27 | 2017-09-27 | Trial Unspecified | 2 | N | 10416337 | TRIAL |
| 10006397 | 10004219 | 1.65 | 66 | Disease modification (D) | 2017-02-14 | 2017-02-26 | Abiraterone | null | null | 10416387 | CVP R |
| 10006398 | 10004220 | 1.82 | 91.4 | Curative (C) | 2015-11-20 | 2015-12-12 | Trial Unspecified | 02 | N | 10416451 | TRIAL |
| 10006399 | 10007204 | 1.58 | 87.2 | Adjuvant (A) | 2015-06-18 | 2015-07-01 | Carboplatin + Pemetrexed | N | N | 10416585 | BCG |
| 10006400 | 10004221 | 1.58 | null | Neo-adjuvant (N) | 2018-06-16 | 2018-06-17 | IBRUTINIB | 02 | N | 10416667 | CTD |
| 10006401 | 10007206 | 1.65 | 70.2 | Palliative (P) | 2018-01-22 | 2018-02-20 | Azacitidine | 2 | N | 10416814 | AZACITIDINE |
| 10006402 | 10004224 | 1.63 | 66.4 | Palliative (P) | 2018-10-05 | 2018-10-06 | Carboplatin + Paclitaxel (3 weekly) | N | N | 10416814 | CARBOPLATIN + PACLITAXEL |
| 10006403 | 10004225 | 1.72 | null | Adjuvant (A) | null | 2016-11-13 | Capecitabine | N | N | 10416885 | CAPECITABINE |
| 10006404 | 10004225 | 1.59 | 73 | Palliative (P) | 2014-05-02 | 2014-05-13 | Trial Unspecified | Y | N | 10416885 | TRIAL |
| 10006405 | 10004228 | 1.63 | 69.5 | Palliative (P) | 2014-04-26 | 2014-06-15 | null | N | N | 10417239 | LENALIDOMIDE |
| 10006406 | 10004228 | 1.68 | 75.8 | Neo-adjuvant (N) | 2018-04-22 | 2018-04-23 | IBRUTINIB | 2 | null | 10417239 | PEMETREXED |
| 10006407 | 10004228 | 1.73 | null | Unknown (U) | 2017-08-08 | 2017-08-30 | BENDAMUSTINE + RITUXIMAB | N | N | 10417239 | BENDAMUSTINE + RITUXIMAB |